Rite Aid Acquires PCS Health Systems for $1.5 Billion

Strategic Insights -

Rite Aid, a Pennsylvania-based retail pharmacy chain, has made a significant move into the healthcare sector by acquiring the pharmacy-benefits management business of Eli Lilly & Company for $1.5 billion. This historic deal marks the first time a drugstore chain has purchased a major pharmacy-benefits manager, allowing Rite Aid to expand its services and negotiate lower prescription drug costs. As a result, Rite Aid is poised to secure more special provider contracts from health maintenance organizations, increasing pressure on competitors to follow suit.

Key Takeaways:

  • Rite Aid's acquisition of PCS Health Systems is valued at $1.5 billion, expanding the company's services and allowing it to negotiate lower prescription drug costs.
  • The deal marks the first time a drugstore chain has purchased a major pharmacy-benefits manager, demonstrating Rite Aid's strategic move into the healthcare sector.
  • Lilly's purchase of PCS in 1994 has come full circle, with Rite Aid acquiring the company for a fraction of the original cost, taking a $2.4 billion write-down on the company last year.
  • Analysts consider Rite Aid's acquisition "smart," predicting more acquisitions of similar companies in the future, citing Robert Izmirlian of Standard & Poor's Equity Group.
  • Rite Aid expects to post a one-time gain of $165 million to $185 million over the current carrying value of the PCS unit.
  • The acquisition is expected to enable Rite Aid to secure more special provider contracts from health maintenance organizations, increasing pressure on competitors.
  • Lilly's stock closed at $82.8125, down $1, while Rite Aid's shares fell to $43.625, down 81.25 cents.

Statistics:

  • $1.5 billion: The purchase price of PCS Health Systems by Rite Aid.
  • $822.125: The price per share of Lilly stock, down $1 from the previous day.
  • $43.625: The price per share of Rite Aid stock, down 81.25 cents.
  • $4.1 billion: The price Lilly paid for PCS in 1994.
  • $2.4 billion: The write-down on PCS by Lilly last year.
  • $165 million: The estimated one-time gain for Rite Aid over the current carrying value of PCS.
  • $185 million: The estimated upper bound of the one-time gain for Rite Aid over the current carrying value of PCS.

Sources:

  • "Rite Aid to buy Lilly pharmacy-benefits unit for $1.5 billion"
  • "Lilly's PCS unit attracts buyer: Rite Aid"
  • "Rite Aid Falls to $43.625 on $1.5 Billion Acquisition"